Oncimmune Regulatory News (ONC)

Director/PDMR/ PCA

No. of Ordinary Shares acquired

Resulting interest

Resulting % holding

Meinhard Schmidt / Tatiana Schmidt

13,000

31,000

0.05%

Tim Bunting

150,000

2,956,717

4.7%

Adam Hill

8,481

40,913

0.06%

Matthew Hall

1,272

11,935

0.02%

Ron Kirschner

1,652

1,652

0.003%

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Meinhard Schmidt / Tatiana Schmidt

2

Reason for the notification

a)

Position/status

Non-executive Chairman / PCA

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oncimmune Holdings plc

b)

LEI

213800HCYIWT6YPI1I02 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each

Identification code

ISIN: GB00BYQ94H38

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price

Volume

£1.17

8,000

£1.21

5,000

d)

Aggregated information

- Aggregated volume

13,000 shares

Weighted average price of £1.185

- Price

e)

Date of the transaction 

4 June 2020

f)

Place of the transaction

London stock exchange, AIM

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Timothy Bunting

2

Reason for the notification

a)

Position/status

Non-executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oncimmune Holdings plc

b)

LEI

213800HCYIWT6YPI1I02 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each

Identification code

ISIN: GB00BYQ94H38

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price

Volume

£1.195

60,000

£1.19

90,000

d)

Aggregated information

- Aggregated volume

150,000 shares

Weighted average price of £1.192

- Price

e)

Date of the transaction 

4 June 2020

f)

Place of the transaction

London stock exchange, AIM

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dr Adam Mark Hill

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oncimmune Holdings plc

b)

LEI

213800HCYIWT6YPI1I02 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each

Identification code

ISIN: GB00BYQ94H38

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price

Volume

£1.179

8,481

d)

Aggregated information

- Aggregated volume

Same as above

- Price

e)

Date of the transaction 

4 June 2020

f)

Place of the transaction

London stock exchange, AIM

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Matthew Hall

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oncimmune Holdings plc

b)

LEI

213800HCYIWT6YPI1I02 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each

Identification code

ISIN: GB00BYQ94H38

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price

Volume

£117.9

1,272

d)

Aggregated information

- Aggregated volume

Same as above

- Price

e)

Date of the transaction 

4 June 2020

f)

Place of the transaction

London stock exchange, AIM

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ron Kirschner

2

Reason for the notification

a)

Position/status

General Counsel and Company Secretary

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oncimmune Holdings plc

b)

LEI

213800HCYIWT6YPI1I02 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each

Identification code

ISIN: GB00BYQ94H38

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price

Volume

£1.204

1,652

d)

Aggregated information

- Aggregated volume

Same as above

- Price

e)

Date of the transaction 

4 June 2020

f)

Place of the transaction

London stock exchange, AIM